Cannabis Stock News: Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC), CBD brand "First & Free" adds topicals to product portfolio

NEW YORK - April 20, 2020 (Investorideas.com Newswire) First & Free, an American-made CBD brand from Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), today announced a new line of CBD Creams: Everyday, Motion and Revitalize. The creams are the latest addition to First & Free's portfolio of hemp-derived CBD isolate products including oil drops and softgel capsules, which launched exclusively in the U.S. last December.

The new product line includes three distinct topical creams with CBD isolate that has been derived from 100% USA-grown hemp. Each 1.76 oz tube contains 2500 mg of CBD, making First & Free the highest strength hemp-derived CBD topical cream on the US market.* The creams have been scientifically formulated using state-of-the-art technology and rigorous testing procedures to ensure the highest level of safety, performance and consistency. Formulated for everyday use, the creams are non-greasy and easy to apply.

• Everyday Cream with CBD: delivers continuous nourishment to areas of your skin that need it most, leaving you balanced, refreshed and rejuvenated.
• Motion Cream with CBD + Arnica: delivers comfort and defends against everyday wear and tear.
• Revitalize Cream with CBD + Capsaicin: naturally revives, nourishes and soothes trouble spots that get on your nerves.

All three topical creams do not contain any parabens, sulphates, glycols, fragrances, or soy.

According to Canopy Growth Chief Commercial Officer David Bigioni, "With our new line of topical creams, First & Free is building a portfolio to treat the everyday stressors that affect both body and mind. We're proud to offer the highest strength topical cream on the US market – up to five times the CBD of other topicals – at a great value."

First & Free products are available online with free two-day shipping to select U.S. states for qualifying orders. First & Free's full product line now includes the following formats:

• Softgels (25mg of CBD each) sold in quantities of 10 or 30 capsules per bottle;
• Softgels (50mg of CBD each) sold in quantities of 30 capsules per bottle;
• Oil Drops, Unflavored or Peppermint (750mg of CBD per 30ml bottle);
• Topical Creams:
  • Everyday Cream with CBD (2500mg per 1.76oz tube)
  • Motion Cream with CBD + Arnica (2500 mg per 1.76oz tube)
  • Revitalize Cream with CBD + Capsaicin (2500mg per 1.76oz tube)

For more information, or to purchase, visit www.firstandfree.com

*Based on product portfolios from the top 5 CBD companies according to Brightfield Research Group 2018-19 data

SOURCE Canopy Growth Corporation

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Buy a cannabis guest post on Investorideas.com